Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: Hepatic manifestation in wilson disease as a consequence of augmented oxidative stress

Pediatric Research

Volumn 60, Issue 4, 2006, Pages 472-477

  Nagasaka, Hironori ^a   Inoue, Ikuo ^b   Inui, Ayano ^c   Komatsu, Haruki ^c   Sogo, Tsuyoshi ^c   Murayama, Kei ^a   Murakami, Tomoko ^a   Yorifuji, Tohru ^d   Asayama, Kotaro ^e   Katayama, Shigeo ^b   Uemoto, Shinji ^f   Kobayashi, Kunihiko ^g   Takayanagi, Masaki ^a   Fujisawa, Tomoo ^c   Tsukahara, Hirokazu ^h  

^a CHIBA CHILDREN'S HOSPITAL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f MIE UNIVERSITY HOSPITAL   (Japan)

^g HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; LIPID PEROXIDATION; LIVER FAILURE; LIVER INJURY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WILSON DISEASE;

ADULT; ANTIOXIDANTS; BLOOD CHEMICAL ANALYSIS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER DISEASES; MALE; OXIDATIVE STRESS; OXIDOREDUCTASES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33748893007     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000238341.12229.d3     Document Type: Article

References (40)

1. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Rass B, Romano DM, Parano E, Pavone L, Brzustowicz LM 1993 The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344-350
2. Scheinberg IH, Sternlieb I 1984 Wilson disease. In: Smith LH (eds) Major Problems in Internal Medicine. Saunders, Philadelphia, pp 1-179
3. Sokol RJ, Narkewicz MR 2001 Copper and iron disorders. In: Suchy FJ, Sokol RJ, Balistreli WF (eds) Liver Disease in Children. Lippincott Williams & Wilkins, Philadelphia, pp 595-640
4. Anderson PJ, Popper H 1960 Change in hepatic structure in Wilson's disease. Am J Pathol 36:483-497
5. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH 1991 Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 100:1129-1134
6. Schilsky ML, Scheinberg IH, Sternlieb I 1991 Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 100:762-767
7. Aust SD, Morehouse LA, Thomas CE 1985 Role of metal in oxygen radical reactions. J Free Radic Biol Med 1:3-25
8. Hochstein P, Kumar KS, Forman SJ 1980 Lipid peroxidation and the cytotoxicity of copper. Ann N Y Acad Sci 355:240-248
9. Sokol RJ, Twedt D, McKim JM Jr, Devereaux MW, Karrer FM, Kam I, von Steigman G, Narkewicz MR, Bacon BR, Britton RS 1994 Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 107:1788-1798
10. Strand S, Hofman WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krammer PH, Galle PR 1998 Hepatic failure and liver cell damage in acute Wilson's disease involve CD95(APO-1/Fas) mediated apoptosis. Nat Med 4:588-593
11. Jimenez I, Aracena P, Letelier ME, Navarro P, Speisky H 2002 Chronic exposure of HepG2 cells to excess copper results in depletion of glutathione and induction of metallothionein. Toxicol In Vitro 16:167-175
12. Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, Corre MP, Prat L, Kuoch V, Basdevant A, Pelletier G, Oppert JM, Buffet C 2005 Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int 25:946-953
13. Summer KH, Eisenburg J 1985 Low content of hepatic reduced glutathione in patients with Wilson's disease. Biochem Med 34:107-111
14. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M 1995 Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 37:219-226
15. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H 1994 Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 20:41-46
16. Angulo P 2002 Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
17. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ 1999 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413-1419
18. Reid AE 2001 Nonalcoholic steatohepatitis. Gastroenterology 121:710-723
19. Okuda M, Li K, Beard MR, Showalter LA, Sholle F, Lemon SM, Weinman SA 2002 Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C core protein. Gastroenterology 122:366-375
20. Tribble DL, Aw TY, Jones DP 1987 The pathological significance of lipid peroxidation in oxidative cell injury. Hepatology 7:377-386
21. Sies H 1993 Strategies of antioxidant defense. Eur J Biochem 215:213-219
22. Fridovich I 1989 Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 264:7761-7764
23. Bedossa P, Poynard T 1996 An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293
24. Gutteridge JM, Halliwell B 1990 The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 129-135.
25. Bando I, Reus MI, Andres D, Cascales M 2005 Endogenous antioxidant defense system in rat liver following mercury chloride oral intoxication. J Biochem Mol Toxicol 19:154-161
26. Tietze F 1969 Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502-522
27. Sies H, Summer KH 1975 Hydroperoxide-metabolizing systems in rat liver. Eur J Biochem 57:503-512
28. Niehaus WG, Samuelson JR, Will ED 1969 Lipid peroxide formation in microsomes. Biochem J 113:315-341
29. McCord JM, Fridovich I 1969 Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055
30. Paglia DE, Valentine WN 1967 Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
31. Inoue I, Noji S, Awata T, Takahashi K, Nakajima T, Sonoda M, Komoda T, Katayama S 1998 Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Life Sci 63:135-144
32. Akerboom TP, Bilzer H, Sies H 1982 The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J Biol Chem 257:4248-4252
33. Gedik N, Kabasakal L, Sehirli O, Ercan F, Sirvanci S, Keyser-Uysal M, Sener G 2005 Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci 76:2593-2606
34. Griffith OW 1999 Biologic and pharmacologic regulation of mammalian glutathion synthesis. Free Radic Biol Med 27:922-935
35. Sies H 1999 Glutathione and its role in cellular functions. Free Radic Biol Med 27:916-921
36. Freedman JH, Ciriolo MR, Peisach J 1989 The role of glutathione in copper metabolism and toxicity. J Biol Chem 264:5598-5605
37. Freedman JH, Peisach J 1989 Intracellular copper transport in cultured hepatome cells. Biochem Biophys Res Commun 164:134-140
38. Jimenez I, Speisky H 2000 Effects of copper ions on the free radical-scavenging properties of reduced glutathione: implication of a complex formation. J Trace Elem Med Biol 14:161-167
39. Sreekumar R, Rosado B, Rasmussen D, Charlton M 2003 Hepatic gene expression in historically progressive nonalcoholic hepatosteatitis. Hepatology 38:244-251
40. Anderson ME, Luo JL 1998 Glutathione therapy: from prodrug and gene. Semin Liver Dis 18:415-424